3
Participants
Start Date
October 31, 2008
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Infliximab
Infliximab 3mg/kg infused intravenously at weeks 0, 2 and 8 and then every 8 weeks until and including week 40 of the study
Imperial College Healthcare NHS Trust, London
Collaborators (1)
Medical Research Council
OTHER_GOV
Imperial College London
OTHER